MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.600
+0.070 (4.58%)
Jan 2, 2026, 4:00 PM EST - Market closed
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $61.23 million as of January 2, 2026. Its market cap has increased by 9.86% in one year.
Market Cap
61.23M
Enterprise Value
49.19M
1-Year Change
9.86%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $61.23M, an increase of 19.81%. That is a compound annual growth rate of 5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 61.23M | 4.58% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 954.17B |
| Johnson & Johnson | 497.71B |
| AbbVie | 405.51B |
| UnitedHealth Group | 305.87B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 262.60B |
| Novo Nordisk | 227.63B |